Neural plasticity, neuropeptides and anxiety in animals - Implications for understanding and treating affective disorder following traumatic stress in humans

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 2, 1998, Pages 301-318

  Adamec, R ^a   Kent, P ^b   Anisman, H ^b   Shallow, T ^a   Merali, Z ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

ACTH; Animal models; Anxiety; AVP; Bombesin; Cat odor; CCK; Corticosterone; CRF; Lasting change; LTP; Path analysis; Predator stress; PTSD; Rat

Indexed keywords

ARGIPRESSIN; BOMBESIN; CHOLECYSTOKININ B RECEPTOR; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; BRAIN STEM; CAT; CONFERENCE PAPER; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHALAMUS NUCLEUS; LIMBIC CORTEX; MALE; MENTAL STRESS; NERVE CELL PLASTICITY; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREDATOR; PRIORITY JOURNAL; RAT;

EID: 0032427889     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(98)00032-3     Document Type: Conference Paper

References (60)

1. Adamec R. E. Does kindling model anything clinically relevant? Biol. Psychiat. 27:1990;249-279.
2. Adamec R. E. Acute and lasting effects of FG-7142 on defensive and approach-attack behavior in cats - implications for models of anxiety which use response suppression. J. Psychopharmacol. 5:1991;29-55.
3. Adamec R. The anxiogenic effects of exposure of rats to natural threat (cats) in two strains of rat - effects on behavior in the elevated plus maze and acoustic startle - further support for a model of post traumatic stress disorder. Annual Meeting of the Behavioral Neuroscience Society, Clear Water, FL, 19-24 May, 1994.
4. Adamec R.E. Transmitter systems involved in neuroplasticity underlying increased anxiety and defense following traumatic stress. Neurosci. Biobehav. Rev. 21(6):1997;755-765.
5. Adamec R. E., McKay D. Amygdala kindling, anxiety, and corticotrophin releasing factor (CRF). Physiol. Behav. 54:1993;423-431.
6. Adamec R. E., McKay D. The effects of CRF and a-helical CRF on anxiety in normal and hypophysectomized rats. J. Psychopharmacol. 7:1993;346-354.
7. Adamec R. E., Shallow T. Lasting effects on rodent anxiety of a single exposure to a cat. Physiol. Behav. 54:1993;101-109.
8. A receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder. Behav. Neurosci. 111(2):1997;435-449.
9. Bentler PM. EQS structural equations progam manual. Encino, CA: Multivariate Software Inc., 1995.
10. Bisette G. Neuropeptides involved in stress and their distribution in the mammalian central nervous system. In: McCubbin JA, Kaufmann PG, Nemeroff CB, editors. Stress, neuropeptides and systemic disease. New York: Academic Press, 1991. pp. 55-72.
11. Blanchard R. J., Blanchard D. C. Antipredator defensive behaviors in a visible burrow system. J. Comp. Psychol. 103:1989;70-82.
12. Blanchard D. C., Blanchard R. J., Rodgers R. J. Pharmacological and neural control of anti-predator defense in the rat. Aggress. Behav. 16:1990;165-175.
13. Blanchard R. J., Blanchard D. C., Rodgers J., Weiss S. M. The characterization and modelling of antipredator defensive behavior. Neurosci. Biobehav. Rev. 14:1990;463-472.
14. Byrne BM. Structural equation modelling with EQS and EQS/Windows. London: Sage Publications, 1994.
15. Cabib S., Puglisi-Allegra S. Opposite responses of mesolimbic dopamine system to controllable and uncontrollable aversive experiences. J. Neurosci. 14:1994;3333-3340.
16. Cruz A. P. M., Frei F., Graeff F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:1994;171-176.
17. Devinsky O., Morrell M. J., Vogt B. A. Contributions of anterior cingulate cortex to behaviour. Brain. 118:1995;279-306.
18. File S. E., Zangrossi H. Jr., Andrews N. Social interaction and elevated plus-maze tests: changes in release and uptake of 5-HT and GABA. Neuropharmacology. 32:1993;217-221.
19. File S. E., Zangrossi H. Jr., Andrews N. Novel environment and cat odor change GABA and 5-HT release and uptake in the rat. Pharmacol. Biochem. Behav. 45:1993;931-934.
20. File S. E., Zangrossi H. Jr., Sanders F. L., Mabbutt P. S. Dissociation between behavioral and corticosterone responses on repeated exposures to cat odor. Physiol. Behav. 54:1993;1109-1111.
21. Grahn R. E., Kalman B. A., Brennan F. X., Watkins L. R., Maier S. F. The elevated plus-maze is not sensitive to the effect of stressor controllability in rats. Pharmacol. Biochem. Behav. 52:1995;565-570.
22. Harbuz M. S., Chalmers J., De Souza L., Lightman S. L. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res. 609:1993;167-173.
23. Heilig M., Koob G. F., Ekman R., Britton K. T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends. Neurosci. 17:1994;80-85.
24. Hendrie C. A., Weiss S. M., Eilam D. Exploration and predation models of anxiety: evidence from laboratory and wild species. Pharmacol. Biochem. Behav. 54(1):1996;13-20.
25. Henke P. G., Ray A. Review, the limbic brain, emotions and stress ulcers. Exp. Clin. Gastroenterol. 1(4):1992;287-292.
26. Herman J. P., Cullinan W. E. Neurocircuitry of stress: central control of hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:1997;78-84.
27. Imaki T., Nahan J.-L., Rivier C., Sawchenko P. E., Vale W. Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11:1991;585-599.
28. Kalin N. H., Takahashi L. K., Chen F.-L. Restraint stress increases corticoptropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus. Brain Res. 656:1994;182-186.
29. Kent P., Anisman H., Merali Z. Are bombesin-like peptides involved in the mediation of the stress response? Life Sci. 62(2):1998;103-114.
30. Kent P, Merali Z. Does bombesin (BN) mediate stress responses through CRF release? Effects of bombesin on brain CRF, plasma ACTH, corticosterone and catecholamines. Summer Neuropeptide Conference, Edgartown, MA, 1996.
31. Kovacs K. J., Sawchenko P. E. Regulation of stress-induced transcriptional changes in hypothalamic neurosecretory neurons. J. Mol. Neurosci. 7:1996;125-133.
32. Landgraf R., Gerstberger R., Montkowski A., Probst J. C., Wotjak C. T., Holsboer F., Engelmann M. V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats. J. Neurosci. 15:1995;4250-4258.
33. Lee S.-Y., Poon W.-Y., Bentler P. M. A three-stage estimation procedure for structureal equation models with ploytomous variables. Psychometrika. 55:1990;45-51.
34. Liebsch G., Wotjak C. T., Landgraf R., Engelmann M. Septal vasopressin modulates anxiety-related behaviour in rats. Neurosci. Lett. 217:1996;101-104.
35. Menzaghi F., Heinrichs S. C., Pich E. M., Weiss F., Koob G. F. The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress. Ann. N.Y. Acad. Sci. 697:1993;142-154.
36. Merali A., Plamondon H., Kent P., Banks K. Corticotropin-releasing factor (CRF) antagonist blocks the autonomic, endocrine, ingestive and behavioral effects of central bombesin (BN). Soc. Neurosci. Abstr. 20:1994;528.1.
37. Merlo Pich E., Koob G. F., Sattler S. C., Menzaghi F., Heilig M., Heinrichs S. C., Vale W., Weiss F. Stress-induced release of corticotropin releasing factor in the amygdala measured by in vivo microdialysis. Soc. Neurosci. Abstr. 18:1992;535.
38. Moldow R. L., Kastin A. L., Graf M., Fischman A. J. Stress mediated changes in hypothalamic corticotropin releasing factor-like immunreactivity. Life Sci. 2:1987;413-418.
39. Murakimi K., Asana S., Dallman M. F., Ganong W. G. Correlation between stress-induced transient increase in corticotropin-releasing hormone content of the median eminence of the hypothalamus and adrenocortotropic hormone secretion. Neuroendocrinology. 49:1989;233-241.
40. Nemeroff C. B. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin-releasing factor. Neuropsychopharmacology. 6:1992;69-75.
41. Olsen L., Knigge U., Warberg J. Gastrin-releasing peptide stimulation of corticotropin secretion in male rats. Endocrinology. 130:1992;2710-2716.
42. Plamondon H., Merali Z. Effects of central neuromedin B and related peptides on blood glucose. Regul. Pept. 47:1993;133-140.
43. Palkovits M., Brownstein M. J., Vale W. Distribution of corticotropin-releasing factor in rat brain. Fed. Proc. 44:1985;215-219.
44. Rivest S., Laflamme N., Nappi R. E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the hypothalamus. J. Neurosci. 15:1995;2680-2695.
45. Rodgers R. J., Cole J. C. Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test. Eur. J. Pharmacol. 261:1994;321-325.
46. Rodgers R. J., Johnson N. J. T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303.
47. Romero L. M., Plotsky P. M., Sapolsky R. M. Patterns of adrenocorticotropin scretagogue release with hypoglycemia, novelty, and Restraint after colchicine blockade of axonal transport. Endocrinology. 132:1993;199-204.
48. Shepherd J. K., Grewal S. S., Fletcher A., Bill D. J., Dourish C. T. Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology. 116:1994;56-64.
49. Short K. R., Maier S. F. Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol. Biochem. Behav. 45:1993;827-835.
50. Silveira M. C. L., Graeff F. G. Defense reaction elicited by microinjection of kainic acid into the medial hypothalamus of the rat: antagonism by a GABAA receptor agonist. Behav. Neur. Biol. 57:1992;226-232.
51. Skolnick P., Paul S. M. New concepts in the neurobiology of anxiety. J. Clin. Psychiat. 44:1983;12-19.
52. Skutella T., Montkowski A., Stöhr T., Probst J. C., Landgraf R., Holsboer F., Jirikowski G. F. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats. Cell. Mol. Neurobiol. 14:1994;579.
53. Speed N., Engdahl B., Schwartz J., Eberly R. Posttraumatic stress disorder as aconsequence of the POW experience. J. Nerv. Ment. Dis. 177(3):1989;147-152.
54. Van der Kolk B. A. The trauma spectrum: the interaction of biological and social events in the genesis of the trauma response. J. Trauma. Stress. 1(3):1988;273-289.
55. Yehuda R., Antelman S. M. Criteria for rationally evaluating animal models of posttraumatic stress disorder. Biol. Psychiat. 33:1993;479-486.
56. Yehuda R., Resnick H., Kahana B., Giller E. L. Long-lasting hormonal alterations to extreme stress in humans: normative or maladaptive. Psychosom. Med. 55:1993;287-297.
57. Zangrossi H. Jr., File S. E. Behavioral consequences in animal tests of anxiety and exploration of exposure to cat odor. Brain Res. Bull. 29:1992;381-388.
58. Zangrossi H. Jr., File S. E. Chlordiazepoxide reduces the generalised anxiety, but not the direct responses, of rats exposed to cat odor. Pharmacol. Biochem. Behav. 43:1992;1195-1200.
59. Zangrossi H. Jr., File S. E. Habituation and generalization of phobic responses to cat odor. Brain Res. Bull. 33:1994;189-194.
60. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association, 1994.